103 related articles for article (PubMed ID: 6135238)
1. The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review.
Sayed Y; Garrison JM
Psychopharmacol Bull; 1983; 19(2):283-8. PubMed ID: 6135238
[No Abstract] [Full Text] [Related]
2. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
Aksent'ev SB; Mokhovikov AN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
[No Abstract] [Full Text] [Related]
3. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
Płaźnik A; Kostowski W
Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
[No Abstract] [Full Text] [Related]
4. [Proceedings: Dopamine receptor and antipsychotic effects (author's transl)].
Karobath M
Arzneimittelforschung; 1976; 26(6):1029-30. PubMed ID: 9103
[No Abstract] [Full Text] [Related]
5. Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.
Bartholini G; Stadler H; Gadea-Ciria M; Lloyd KG
Adv Biochem Psychopharmacol; 1977; 16():391-5. PubMed ID: 18888
[No Abstract] [Full Text] [Related]
6. The neuropathology of schizophrenia.
Bachus SE; Kleinman JE
J Clin Psychiatry; 1996; 57 Suppl 11():72-83. PubMed ID: 8941174
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic neuroleptic treatment on tyrosine hydroxylase in dopaminergic terminals: comparisons between drugs and brain regions reveals different mechanisms of tolerance.
Gale K
Adv Biochem Psychopharmacol; 1980; 24():23-9. PubMed ID: 6105777
[No Abstract] [Full Text] [Related]
8. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
[No Abstract] [Full Text] [Related]
9. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
Di Pietro NC; Seamans JK
Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940
[TBL] [Abstract][Full Text] [Related]
10. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Neuroscience; 1978; 3(9):773-83. PubMed ID: 30919
[No Abstract] [Full Text] [Related]
11. [Schizophrenia: a psychobiological view].
Rodríguez-Arias M; Aguilar MA; Espert R; Miñarro J
Rev Neurol; 1996 Oct; 24(134):1210-20. PubMed ID: 8983716
[TBL] [Abstract][Full Text] [Related]
12. [Dopamine hypothesis in schizophrenia--recent findings in limbic system abnormality].
Toru M; Watanabe S; Kaneno S
Nihon Rinsho; 1978; 36(1):76-82. PubMed ID: 24768
[No Abstract] [Full Text] [Related]
13. Striatal and limbic dopamine function: evidence from animal studies.
Alpert JE; Iversen SD
Ann Neurol; 1983 May; 13(5):578. PubMed ID: 6683480
[No Abstract] [Full Text] [Related]
14. From pharmacological profiles to clinical outcomes.
Kerwin R
Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S1-4. PubMed ID: 11252517
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
16. A critique of the dopamine hypothesis of schizophrenia and psychosis.
Moncrieff J
Harv Rev Psychiatry; 2009; 17(3):214-25. PubMed ID: 19499420
[TBL] [Abstract][Full Text] [Related]
17. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
Hertel P
Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
[TBL] [Abstract][Full Text] [Related]
18. [Effect of long-term neuroleptic administration on CNS receptors plasticity].
Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO
Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099
[No Abstract] [Full Text] [Related]
19. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.
Laruelle M; Frankle WG; Narendran R; Kegeles LS; Abi-Dargham A
Clin Ther; 2005; 27 Suppl A():S16-24. PubMed ID: 16198197
[TBL] [Abstract][Full Text] [Related]
20. Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
Meltzer HY
Psychopharmacology (Berl); 2002 Aug; 163(1):1-3. PubMed ID: 12185394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
